Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
13MAY

Dex closes $5.3m matching ML talent

2 min read
20:05UTC

Dex closed a $5.3m seed on Tuesday 28 April from Notion Capital, a16z Speedrun, Concept Ventures and OpenAI angels at $1.8m of annualised recurring revenue, matching machine-learning engineers to clients including Granola, Synthesia and ElevenLabs.

TechnologyDeveloping
Key takeaway

Dex closed $5.3m on 28 April at $1.8m ARR with Notion Capital and OpenAI angels.

Dex closed a $5.3 million seed on 28 April 2026 with $1.8 million of ARR (annualised recurring revenue) 1. Notion Capital led; a16z Speedrun, Concept Ventures and angels from OpenAI participated. The London platform matches machine-learning engineers to clients including Granola, Synthesia and ElevenLabs.

Dex's syndicate is the post-VCT-cut investor map at the AI talent tier in pure form. Notion Capital plus a16z Speedrun plus Concept Ventures plus OpenAI angels reads as a syndicate built for AI-native bets at the seed stage; retail-investor pools from the relief regime that closed earlier in April do not appear. OpenAI angels in particular write into companies that touch the model layer or its labour market, and Dex's product is an explicit hire-side bet on that labour market.

Granola's presence as a Dex client is a data point on the density of London's AI ecosystem. The note-taking unicorn raised $125m at a $1.5bn valuation in March and is now sourcing ML talent through a London-based platform that itself has British investors and American operator angels, which is the kind of within-cluster flow that turns regional density into a moat.

The ARR-to-round ratio also matters. $1.8m of ARR against a $5.3m seed implies a multiple in the high single digits, modest by AI-platform standards and consistent with a syndicate that is pricing on operator-network economics rather than topline growth. The bet is that OpenAI angels and Notion Capital can route demand from their portfolios; the cheque is paying for the network advantage the platform inherits.

Deep Analysis

In plain English

Dex helps companies hire machine-learning engineers, the specialists who build and maintain AI systems. Instead of posting job adverts on LinkedIn, companies pay Dex to match them with vetted ML engineers who are open to new work. At $1.8m in annualised recurring revenue, Dex already has paying customers. The $5.3m seed raised on 28 April funds growth of the matching platform, including the team needed to vet more engineers and serve more clients. OpenAI investors joined the round, which signals that Dex's client network overlaps with companies building products on OpenAI's technology. Those companies are among the fastest-growing engineering employers in the UK right now, and OpenAI benefits when its customers can hire AI talent faster.

First Reported In

Update #3 · SAIU rides $1.1bn Ineffable seed; hardware looms

Beauhurst· 1 May 2026
Read original
Causes and effects
This Event
Dex closes $5.3m matching ML talent
The cap table demonstrates how international AI-native investors and operator angels are filling the seed-stage gap that retail VCT networks no longer serve.
Different Perspectives
Australian Department of Defence (AUKUS AI for Acoustics partner)
Australian Department of Defence (AUKUS AI for Acoustics partner)
Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.
DSIT / Liz Kendall, Secretary of State for Science
DSIT / Liz Kendall, Secretary of State for Science
DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.
Beauhurst / UK startup data analysts
Beauhurst / UK startup data analysts
Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.